<?xml version="1.0" encoding="UTF-8"?>
<p>Arthritis is a fundamental autoimmune disease, causes chronic inflammation in the jointsâ€™ connective tissue, leads to progression of synovial inflammation and cartilage destruction [
 <xref rid="B1-molecules-25-04737" ref-type="bibr">1</xref>]. Many researchers reported that pro-inflammatory mediators like tumour necrosis factor (TNF)-alpha, interleukin (IL)-2 and enzymes are the potential stimulators of developing persistent and multiple disorders [
 <xref rid="B2-molecules-25-04737" ref-type="bibr">2</xref>]. Nevertheless, a direct or indirect relationship between arthritis and these mediators is not surprising. To lessen the rheumatoid arthritis, various non-steroidal anti-inflammatory drugs (NSAIDs) (e.g., aspirin, ibuprofen, indomethacin, etc.) are being used clinically, but have several limitations (i.e., insufficient therapeutic interventions) and undesired side effects, such as amnesia, memory disturbance, drowsiness and sexual dysfunction.
</p>
